表紙:妊婦向け薬品の世界市場の規模:薬品クラス別、妊娠段階別、流通チャネル別、業界、地域の見通し、成長可能性、競合の市場シェア、予測(2023年~2032年)
市場調査レポート
商品コード
1149036

妊婦向け薬品の世界市場の規模:薬品クラス別、妊娠段階別、流通チャネル別、業界、地域の見通し、成長可能性、競合の市場シェア、予測(2023年~2032年)

Pregnancy Medication Market Size By Drug Class, By Pregnancy Stage, By Distribution Channel, Industry Analysis Report, Regional Outlook, Growth Potential, Competitive Market Share & Forecast, 2023 - 2032

出版日: | 発行: Global Market Insights Inc. | ページ情報: 英文 255 Pages | 納期: 2~3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.92円
妊婦向け薬品の世界市場の規模:薬品クラス別、妊娠段階別、流通チャネル別、業界、地域の見通し、成長可能性、競合の市場シェア、予測(2023年~2032年)
出版日: 2022年10月31日
発行: Global Market Insights Inc.
ページ情報: 英文 255 Pages
納期: 2~3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の妊婦向け薬品の市場規模は、妊婦の栄養不足の急増により、2032年までに有利な成長を示し、かなりの市場規模を記録すると予測されています。

当レポートでは、世界の妊婦向け薬品市場について調査分析し、業界の考察、セグメント分析、地域分析、企業プロファイルなどを提供しています。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 妊婦向け薬品業界の考察

  • 業界セグメンテーション
  • 業界情勢(2018年~2032年)
  • 業界の影響要因
    • 成長促進要因
    • 業界の潜在的リスク・課題
  • 成長可能性分析
    • 薬品クラス別
    • 妊娠段階別
    • 流通チャネル別
  • COVID-19の影響の分析
  • 妊婦と妊娠していない女性の栄養の推奨と1日あたりの摂取許容量の比較分析
  • 規制情勢
    • 米国
    • 欧州
  • ポーターのファイブフォース分析
  • PESTLE分析

第4章 競合情勢(2021年)

  • イントロダクション
  • 企業マトリックス分析(2021年)
  • 戦略ダッシュボード(2021年)

第5章 妊婦向け薬品市場:薬品クラス別

  • 主なセグメントの動向
  • 貧血
  • 制酸剤
  • 抗アレルギー剤
  • 鎮痛剤
  • 抗菌剤
  • ホルモン
  • 下剤
  • ワクチン
  • 栄養サプリメント
    • 市場規模:地域別(2018年~2032年)
    • ミネラル
    • オメガ3
    • 葉酸
    • ビタミン
    • マルチビタミン
    • その他
  • その他

第6章 妊婦向け薬品市場:妊娠段階別

  • 主なセグメントの動向
  • 第1期
  • 第2期
  • 第3期

第7章 妊婦向け薬品市場:流通チャネル別

  • 主なセグメントの動向
  • 病院薬局
  • 小売薬局
  • オンライン薬局

第8章 妊婦向け薬品市場:地域別

  • 主な地域の動向
  • 北米
    • 市場規模:国別(2018年~2032年)
    • 市場規模:薬品クラス別(2018年~2032年)
    • 市場規模:妊娠段階別(2018年~2032年)
    • 市場規模:流通チャネル別(2018年~2032年)
    • 米国
    • カナダ
  • 欧州
    • 市場規模:国別(2018年~2032年)
    • 市場規模:薬品クラス別(2018年~2032年)
    • 市場規模:妊娠段階別(2018年~2032年)
    • 市場規模:流通チャネル別(2018年~2032年)
    • ドイツ
    • 英国
    • フランス
    • イタリア
    • スペイン
  • アジア太平洋
    • 市場規模:国別(2018年~2032年)
    • 市場規模:薬品クラス別(2018年~2032年)
    • 市場規模:妊娠段階別(2018年~2032年)
    • 市場規模:流通チャネル別(2018年~2032年)
    • 中国
    • 日本
    • インド
    • オーストラリア
    • 韓国
  • ラテンアメリカ
    • 市場規模:国別(2018年~2032年)
    • 市場規模:薬品クラス別(2018年~2032年)
    • 市場規模:妊娠段階別(2018年~2032年)
    • 市場規模:流通チャネル別(2018年~2032年)
    • ブラジル
    • メキシコ
    • アルゼンチン
  • 中東・アフリカ
    • 市場規模:国別(2018年~2032年)
    • 市場規模:薬品クラス別(2018年~2032年)
    • 市場規模:妊娠段階別(2018年~2032年)
    • 市場規模:流通チャネル別(2018年~2032年)
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦

第9章 企業プロファイル

  • F. Hoffmann-La Roche Ltd
  • Alkem Laboratories Limited
  • Piramal Enterprises Limited
  • Cipla Limited
  • Pfizer Inc
  • Dr. Reddy's Laboratories
  • Alembic Pharmaceuticals Ltd
  • Lupin Limited
  • Glenmark Pharmaceuticals Ltd
  • Viatris Inc. (Mylan Inc.)
  • Amgen Inc
図表

Data Tables

  • TABLE 1 Global pregnancy medication market, 2018 - 2022 (USD Million)
  • TABLE 2 Global pregnancy medication market, 2023 - 2032 (USD Million)
  • TABLE 3 Global pregnancy medication market, by drug class, 2018 - 2022 (USD Million)
  • TABLE 4 Global pregnancy medication market, by drug class, 2023 - 2032 (USD Million)
  • TABLE 5 Global pregnancy medication market, by pregnancy stage, 2018 - 2022 (USD Million)
  • TABLE 6 Global pregnancy medication market, by pregnancy stage, 2023 - 2032 (USD Million)
  • TABLE 7 Global pregnancy medication market, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 8 Global pregnancy medication market, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 9 Global pregnancy medication market, by region, 2018 - 2022 (USD Million)
  • TABLE 10 Global pregnancy medication market, by region, 2023 - 2032 (USD Million)
  • TABLE 11 Industry impact forces
  • TABLE 12 Antianemia market size, by region, 2018 - 2022 (USD Million)
  • TABLE 13 Antianemia market size, by region, 2023 - 2032 (USD Million)
  • TABLE 14 Antacids market size, by region, 2018 - 2022 (USD Million)
  • TABLE 15 Antacids market size, by region, 2023 - 2032 (USD Million)
  • TABLE 16 Antiallergic market size, by region, 2018 - 2022 (USD Million)
  • TABLE 17 Antiallergic market size, by region, 2023 - 2032 (USD Million)
  • TABLE 18 Analgesics market size, by region, 2018 - 2022 (USD Million)
  • TABLE 19 Analgesics market size, by region, 2023 - 2032 (USD Million)
  • TABLE 20 Antimicrobials market size, by region, 2018 - 2022 (USD Million)
  • TABLE 21 Antimicrobials market size, by region, 2023 - 2032 (USD Million)
  • TABLE 22 Hormones market size, by region, 2018 - 2022 (USD Million)
  • TABLE 23 Hormones market size, by region, 2023 - 2032 (USD Million)
  • TABLE 24 Laxatives market size, by region, 2018 - 2022 (USD Million)
  • TABLE 25 Laxatives market size, by region, 2023 - 2032 (USD Million)
  • TABLE 26 Vaccines market size, by region, 2018 - 2022 (USD Million)
  • TABLE 27 Vaccines market size, by region, 2023 - 2032 (USD Million)
  • TABLE 28 Nutritional supplements market size, by region, 2018 - 2022 (USD Million)
  • TABLE 29 Nutritional supplements market size, by region, 2023 - 2032 (USD Million)
  • TABLE 30 Minerals market size, by region, 2018 - 2022 (USD Million)
  • TABLE 31 Minerals market size, by region, 2023 - 2032 (USD Million)
  • TABLE 32 Omega 3 market size, by region, 2018 - 2022 (USD Million)
  • TABLE 33 Omega 3 market size, by region, 2023 - 2032 (USD Million)
  • TABLE 34 Folic acid market size, by region, 2018 - 2022 (USD Million)
  • TABLE 35 Folic acid market size, by region, 2023 - 2032 (USD Million)
  • TABLE 36 Vitamins market size, by region, 2018 - 2022 (USD Million)
  • TABLE 37 Vitamins market size, by region, 2023 - 2032 (USD Million)
  • TABLE 38 Multivitamins market size, by region, 2018 - 2022 (USD Million)
  • TABLE 39 Multivitamins market size, by region, 2023 - 2032 (USD Million)
  • TABLE 40 Others market size, by region, 2018 - 2022 (USD Million)
  • TABLE 41 Others market size, by region, 2023 - 2032 (USD Million)
  • TABLE 42 1st trimester market size, by region, 2018 - 2022 (USD Million)
  • TABLE 43 1st trimester market size, by region, 2023 - 2032 (USD Million)
  • TABLE 44 2nd trimester market size, by region, 2018 - 2022 (USD Million)
  • TABLE 45 2nd trimester market size, by region, 2023 - 2032 (USD Million)
  • TABLE 46 3rd trimester market size, by region, 2018 - 2022 (USD Million)
  • TABLE 47 3rd trimester market size, by region, 2023 - 2032 (USD Million)
  • TABLE 48 Hospital pharmacy market size, by region, 2018 - 2022 (USD Million)
  • TABLE 49 Hospital pharmacy market size, by region, 2023 - 2032 (USD Million)
  • TABLE 50 Retail pharmacy market size, by region, 2018 - 2022 (USD Million)
  • TABLE 51 Retail pharmacy market size, by region, 2023 - 2032 (USD Million)
  • TABLE 52 Online pharmacy market size, by region, 2018 - 2022 (USD Million)
  • TABLE 53 Online pharmacy market size, by region, 2023 - 2032 (USD Million)
  • TABLE 54 North America pregnancy medication Market size, by country, 2018 - 2022 (USD Million)
  • TABLE 55 North America pregnancy medication Market size, by country, 2023 - 2032 (USD Million)
  • TABLE 56 North America pregnancy medication market size, by drug class, 2018 - 2022 (USD Million)
  • TABLE 57 North America pregnancy medication market size, by drug class, 2023 - 2032 (USD Million)
  • TABLE 58 North America pregnancy medication market size, by nutritional supplements, 2018 - 2022 (USD Million)
  • TABLE 59 North America pregnancy medication market size, by nutritional supplements, 2023 - 2032 (USD Million)
  • TABLE 60 North America pregnancy medication market size, by pregnancy stage, 2018 - 2022 (USD Million)
  • TABLE 61 North America pregnancy medication market size, by pregnancy stage, 2023 - 2032 (USD Million)
  • TABLE 62 North America pregnancy medication market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 63 North America pregnancy medication market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 64 U.S. pregnancy medication market size, by drug class, 2018 - 2022 (USD Million)
  • TABLE 65 U.S. pregnancy medication market size, by drug class, 2023 - 2032 (USD Million)
  • TABLE 66 U.S. pregnancy medication market size, by nutritional supplements, 2018 - 2022 (USD Million)
  • TABLE 67 U.S. pregnancy medication market size, by nutritional supplements, 2023 - 2032 (USD Million)
  • TABLE 68 U.S. pregnancy medication market size, by pregnancy stage, 2018 - 2022 (USD Million)
  • TABLE 69 U.S. pregnancy medication market size, by pregnancy stage, 2023 - 2032 (USD Million)
  • TABLE 70 U.S. pregnancy medication market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 71 U.S. pregnancy medication market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 72 Canada pregnancy medication market size, by drug class, 2018 - 2022 (USD Million)
  • TABLE 73 Canada pregnancy medication market size, by drug class, 2023 - 2032 (USD Million)
  • TABLE 74 Canada pregnancy medication market size, by nutritional supplements, 2018 - 2022 (USD Million)
  • TABLE 75 Canada pregnancy medication market size, by nutritional supplements, 2023 - 2032 (USD Million)
  • TABLE 76 Canada pregnancy medication market size, by pregnancy stage, 2018 - 2022 (USD Million)
  • TABLE 77 Canada pregnancy medication market size, by pregnancy stage, 2023 - 2032 (USD Million)
  • TABLE 78 Canada pregnancy medication market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 79 Canada pregnancy medication market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 80 Europe pregnancy medication Market size, by country, 2018 - 2022 (USD Million)
  • TABLE 81 Europe pregnancy medication Market size, by country, 2023 - 2032 (USD Million)
  • TABLE 82 Europe pregnancy medication market size, by drug class, 2018 - 2022 (USD Million)
  • TABLE 83 Europe pregnancy medication Market size, by drug class, 2023 - 2032 (USD Million)
  • TABLE 84 Europe pregnancy medication market size, by nutritional supplements, 2018 - 2022 (USD Million)
  • TABLE 85 Europe pregnancy medication market size, by nutritional supplements, 2023 - 2032 (USD Million)
  • TABLE 86 Europe pregnancy medication market size, by pregnancy stage, 2018 - 2022 (USD Million)
  • TABLE 87 Europe pregnancy medication Market size, by pregnancy stage, 2023 - 2032 (USD Million)
  • TABLE 88 Europe pregnancy medication market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 89 Europe pregnancy medication market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 90 Germany pregnancy medication market size, by drug class, 2018 - 2022 (USD Million)
  • TABLE 91 Germany pregnancy medication market size, by drug class, 2023 - 2032 (USD Million)
  • TABLE 92 Germany pregnancy medication market size, by nutritional supplements, 2018 - 2022 (USD Million)
  • TABLE 93 Germany pregnancy medication market size, by nutritional supplements, 2023 - 2032 (USD Million)
  • TABLE 94 Germany pregnancy medication market size, by pregnancy stage, 2018 - 2022 (USD Million)
  • TABLE 95 Germany pregnancy medication market size, by pregnancy stage, 2023 - 2032 (USD Million)
  • TABLE 96 Germany pregnancy medication market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 97 Germany pregnancy medication market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 98 UK pregnancy medication market size, by drug class, 2018 - 2022 (USD Million)
  • TABLE 99 UK pregnancy medication market size, by drug class, 2023 - 2032 (USD Million)
  • TABLE 100 UK pregnancy medication market size, by nutritional supplements, 2018 - 2022 (USD Million)
  • TABLE 101 UK pregnancy medication market size, by nutritional supplements, 2023 - 2032 (USD Million)
  • TABLE 102 UK pregnancy medication market size, by pregnancy stage, 2018 - 2022 (USD Million)
  • TABLE 103 UK pregnancy medication market size, by pregnancy stage, 2023 - 2032 (USD Million)
  • TABLE 104 UK pregnancy medication market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 105 UK pregnancy medication market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 106 France pregnancy medication market size, by drug class, 2018 - 2022 (USD Million)
  • TABLE 107 France pregnancy medication market size, by drug class, 2023 - 2032 (USD Million)
  • TABLE 108 France pregnancy medication market size, by nutritional supplements, 2018 - 2022 (USD Million)
  • TABLE 109 France pregnancy medication market size, by nutritional supplements, 2023 - 2032 (USD Million)
  • TABLE 110 France pregnancy medication market size, by pregnancy stage, 2018 - 2022 (USD Million)
  • TABLE 111 France pregnancy medication market size, by pregnancy stage, 2023 - 2032 (USD Million)
  • TABLE 112 France pregnancy medication market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 113 France pregnancy medication market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 114 Italy pregnancy medication market size, by drug class, 2018 - 2022 (USD Million)
  • TABLE 115 Italy pregnancy medication market size, by drug class, 2023 - 2032 (USD Million)
  • TABLE 116 Italy pregnancy medication market size, by nutritional supplements, 2018 - 2022 (USD Million)
  • TABLE 117 Italy pregnancy medication market size, by nutritional supplements, 2023 - 2032 (USD Million)
  • TABLE 118 Italy pregnancy medication market size, by pregnancy stage, 2018 - 2022 (USD Million)
  • TABLE 119 Italy pregnancy medication market size, by pregnancy stage, 2023 - 2032 (USD Million)
  • TABLE 120 Italy pregnancy medication market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 121 Italy pregnancy medication market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 122 Spain pregnancy medication market size, by drug class, 2018 - 2022 (USD Million)
  • TABLE 123 Spain pregnancy medication market size, by drug class, 2023 - 2032 (USD Million)
  • TABLE 124 Spain pregnancy medication market size, by nutritional supplements, 2018 - 2022 (USD Million)
  • TABLE 125 Spain pregnancy medication market size, by nutritional supplements, 2023 - 2032 (USD Million)
  • TABLE 126 Spain pregnancy medication market size, by pregnancy stage, 2018 - 2022 (USD Million)
  • TABLE 127 Spain pregnancy medication market size, by pregnancy stage, 2023 - 2032 (USD Million)
  • TABLE 128 Spain pregnancy medication market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 129 Spain pregnancy medication market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 130 Asia Pacific pregnancy medication Market size, by country, 2018 - 2022 (USD Million)
  • TABLE 131 Asia Pacific pregnancy medication Market size, by country, 2023 - 2032 (USD Million)
  • TABLE 132 Asia Pacific pregnancy medication market size, by drug class, 2018 - 2022 (USD Million)
  • TABLE 133 Asia Pacific pregnancy medication market size, by drug class, 2023 - 2032 (USD Million)
  • TABLE 134 Asia Pacific pregnancy medication market size, by nutritional supplements, 2018 - 2022 (USD Million)
  • TABLE 135 Asia Pacific pregnancy medication market size, by nutritional supplements, 2023 - 2032 (USD Million)
  • TABLE 136 Asia Pacific pregnancy medication market size, by pregnancy stage, 2018 - 2022 (USD Million)
  • TABLE 137 Asia Pacific pregnancy medication market size, by pregnancy stage, 2023 - 2032 (USD Million)
  • TABLE 138 Asia Pacific pregnancy medication market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 139 Asia Pacific pregnancy medication market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 140 India pregnancy medication market size, by drug class, 2018 - 2022 (USD Million)
  • TABLE 141 India pregnancy medication market size, by drug class, 2023 - 2032 (USD Million)
  • TABLE 142 India pregnancy medication market size, by nutritional supplements, 2018 - 2022 (USD Million)
  • TABLE 143 India pregnancy medication market size, by nutritional supplements, 2023 - 2032 (USD Million)
  • TABLE 144 India pregnancy medication market size, by pregnancy stage, 2018 - 2022 (USD Million)
  • TABLE 145 India pregnancy medication market size, by pregnancy stage, 2023 - 2032 (USD Million)
  • TABLE 146 India pregnancy medication market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 147 India pregnancy medication market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 148 China pregnancy medication market size, by drug class, 2018 - 2022 (USD Million)
  • TABLE 149 China pregnancy medication market size, by drug class, 2023 - 2032 (USD Million)
  • TABLE 150 China pregnancy medication market size, by nutritional supplements, 2018 - 2022 (USD Million)
  • TABLE 151 China pregnancy medication market size, by nutritional supplements, 2023 - 2032 (USD Million)
  • TABLE 152 China pregnancy medication market size, by pregnancy stage, 2018 - 2022 (USD Million)
  • TABLE 153 China pregnancy medication market size, by pregnancy stage, 2023 - 2032 (USD Million)
  • TABLE 154 China pregnancy medication market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 155 China pregnancy medication market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 156 Japan pregnancy medication market size, by drug class, 2018 - 2022 (USD Million)
  • TABLE 157 Japan pregnancy medication market size, by drug class, 2023 - 2032 (USD Million)
  • TABLE 158 Japan pregnancy medication market size, by nutritional supplements, 2018 - 2022 (USD Million)
  • TABLE 159 Japan pregnancy medication market size, by nutritional supplements, 2023 - 2032 (USD Million)
  • TABLE 160 Japan pregnancy medication market size, by pregnancy stage, 2018 - 2022 (USD Million)
  • TABLE 161 Japan pregnancy medication market size, by pregnancy stage, 2023 - 2032 (USD Million)
  • TABLE 162 Japan pregnancy medication market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 163 Japan pregnancy medication market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 164 Australia pregnancy medication market size, by drug class, 2018 - 2022 (USD Million)
  • TABLE 165 Australia pregnancy medication market size, by drug class, 2023 - 2032 (USD Million)
  • TABLE 166 Australia pregnancy medication market size, by nutritional supplements, 2018 - 2022 (USD Million)
  • TABLE 167 Australia pregnancy medication market size, by nutritional supplements, 2023 - 2032 (USD Million)
  • TABLE 168 Australia pregnancy medication market size, by pregnancy stage, 2018 - 2022 (USD Million)
  • TABLE 169 Australia pregnancy medication market size, by pregnancy stage, 2023 - 2032 (USD Million)
  • TABLE 170 Australia pregnancy medication market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 171 Australia pregnancy medication market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 172 South Korea pregnancy medication market size, by drug class, 2018 - 2022 (USD Million)
  • TABLE 173 South Korea pregnancy medication market size, by drug class, 2023 - 2032 (USD Million)
  • TABLE 174 South Korea pregnancy medication market size, by nutritional supplements, 2018 - 2022 (USD Million)
  • TABLE 175 South Korea pregnancy medication market size, by nutritional supplements, 2023 - 2032 (USD Million)
  • TABLE 176 South Korea pregnancy medication market size, by pregnancy stage, 2018 - 2022 (USD Million)
  • TABLE 177 South Korea pregnancy medication market size, by pregnancy stage, 2023 - 2032 (USD Million)
  • TABLE 178 South Korea pregnancy medication market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 179 South Korea pregnancy medication market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 180 Latin America pregnancy medication Market size, by country, 2018 - 2022 (USD Million)
  • TABLE 181 Latin America pregnancy medication Market size, by country, 2023 - 2032 (USD Million)
  • TABLE 182 Latin America pregnancy medication market size, by drug class, 2018 - 2022 (USD Million)
  • TABLE 183 Latin America pregnancy medication market size, by drug class, 2023 - 2032 (USD Million)
  • TABLE 184 Latin America pregnancy medication market size, by nutritional supplements, 2018 - 2022 (USD Million)
  • TABLE 185 Latin America pregnancy medication market size, by nutritional supplements, 2023 - 2032 (USD Million)
  • TABLE 186 Latin America pregnancy medication market size, by pregnancy stage, 2018 - 2022 (USD Million)
  • TABLE 187 Latin America pregnancy medication market size, by pregnancy stage, 2023 - 2032 (USD Million)
  • TABLE 188 Latin America pregnancy medication market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 189 Latin America pregnancy medication market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 190 Brazil pregnancy medication market size, by drug class, 2018 - 2022 (USD Million)
  • TABLE 191 Brazil pregnancy medication market size, by drug class, 2023 - 2032 (USD Million)
  • TABLE 192 Brazil pregnancy medication market size, by nutritional supplements, 2018 - 2022 (USD Million)
  • TABLE 193 Brazil pregnancy medication market size, by nutritional supplements, 2023 - 2032 (USD Million)
  • TABLE 194 Brazil pregnancy medication market size, by pregnancy stage, 2018 - 2022 (USD Million)
  • TABLE 195 Brazil pregnancy medication market size, by pregnancy stage, 2023 - 2032 (USD Million)
  • TABLE 196 Brazil pregnancy medication market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 197 Brazil pregnancy medication market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 198 Mexico pregnancy medication market size, by drug class, 2018 - 2022 (USD Million)
  • TABLE 199 Mexico pregnancy medication market size, by drug class, 2023 - 2032 (USD Million)
  • TABLE 200 Mexico pregnancy medication market size, by nutritional supplements, 2018 - 2022 (USD Million)
  • TABLE 201 Mexico pregnancy medication market size, by nutritional supplements, 2023 - 2032 (USD Million)
  • TABLE 202 Mexico pregnancy medication market size, by pregnancy stage, 2018 - 2022 (USD Million)
  • TABLE 203 Mexico pregnancy medication market size, by pregnancy stage, 2023 - 2032 (USD Million)
  • TABLE 204 Mexico pregnancy medication market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 205 Mexico pregnancy medication market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 206 Argentina pregnancy medication market size, by drug class, 2018 - 2022 (USD Million)
  • TABLE 207 Argentina pregnancy medication market size, by drug class, 2023 - 2032 (USD Million)
  • TABLE 208 Argentina pregnancy medication market size, by nutritional supplements, 2018 - 2022 (USD Million)
  • TABLE 209 Argentina pregnancy medication market size, by nutritional supplements, 2023 - 2032 (USD Million)
  • TABLE 210 Argentina pregnancy medication market size, by pregnancy stage, 2018 - 2022 (USD Million)
  • TABLE 211 Argentina pregnancy medication market size, by pregnancy stage, 2023 - 2032 (USD Million)
  • TABLE 212 Argentina pregnancy medication market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 213 Argentina pregnancy medication market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 214 MEA pregnancy medication market size, by country, 2018 - 2022 (USD Million)
  • TABLE 215 MEA pregnancy medication market size, by country, 2023 - 2032 (USD Million)
  • TABLE 216 MEA pregnancy medication market size, by drug class, 2018 - 2022 (USD Million)
  • TABLE 217 MEA pregnancy medication market size, by drug class, 2023 - 2032 (USD Million)
  • TABLE 218 MEA pregnancy medication market size, by nutritional supplements, 2018 - 2022 (USD Million)
  • TABLE 219 MEA pregnancy medication market size, by nutritional supplements, 2023 - 2032 (USD Million)
  • TABLE 220 MEA pregnancy medication market size, by pregnancy stage, 2018 - 2022 (USD Million)
  • TABLE 221 MEA pregnancy medication market size, by pregnancy stage, 2023 - 2032 (USD Million)
  • TABLE 222 MEA pregnancy medication market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 223 MEA pregnancy medication market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 224 South Africa pregnancy medication market size, by drug class, 2018 - 2022 (USD Million)
  • TABLE 225 South Africa pregnancy medication market size, by drug class, 2023 - 2032 (USD Million)
  • TABLE 226 South Africa pregnancy medication market size, by nutritional supplements, 2018 - 2022 (USD Million)
  • TABLE 227 South Africa pregnancy medication market size, by nutritional supplements, 2023 - 2032 (USD Million)
  • TABLE 228 South Africa pregnancy medication market size, by pregnancy stage, 2018 - 2022 (USD Million)
  • TABLE 229 South Africa pregnancy medication market size, by pregnancy stage, 2023 - 2032 (USD Million)
  • TABLE 230 South Africa pregnancy medication market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 231 South Africa pregnancy medication market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 232 Saudi Arabia pregnancy medication market size, by drug class, 2018 - 2022 (USD Million)
  • TABLE 233 Saudi Arabia pregnancy medication market size, by drug class, 2023 - 2032 (USD Million)
  • TABLE 234 Saudi Arabia pregnancy medication market size, by nutritional supplements, 2018 - 2022 (USD Million)
  • TABLE 235 Saudi Arabia pregnancy medication market size, by nutritional supplements, 2023 - 2032 (USD Million)
  • TABLE 236 Saudi Arabia pregnancy medication market size, by pregnancy stage, 2018 - 2022 (USD Million)
  • TABLE 237 Saudi Arabia pregnancy medication market size, by pregnancy stage, 2023 - 2032 (USD Million)
  • TABLE 238 Saudi Arabia pregnancy medication market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 239 Saudi Arabia pregnancy medication market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 240 UAE pregnancy medication market size, by drug class, 2018 - 2022 (USD Million)
  • TABLE 241 UAE pregnancy medication market size, by drug class, 2023 - 2032 (USD Million)
  • TABLE 242 UAE pregnancy medication market size, by nutritional supplements, 2018 - 2022 (USD Million)
  • TABLE 243 UAE. pregnancy medication market size, by nutritional supplements, 2023 - 2032 (USD Million)
  • TABLE 244 UAE pregnancy medication market size, by pregnancy stage, 2018 - 2022 (USD Million)
  • TABLE 245 UAE pregnancy medication market size, by pregnancy stage, 2023 - 2032 (USD Million)
  • TABLE 246 UAE pregnancy medication market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 247 UAE pregnancy medication market size, by distribution channel, 2023 - 2032 (USD Million)

Charts & Figures

  • FIG. 1 Pregnancy medication industry 360 degree synopsis, 2018 - 2032
  • FIG. 2 Industry segmentation
  • FIG. 3 Global pregnancy medication market, 2018 - 2032 (USD Million)
  • FIG. 4 Growth potential analysis, by drug class
  • FIG. 5 Growth potential analysis, by pregnancy stage
  • FIG. 6 Growth potential analysis, by distribution channel
  • FIG. 7 Porter's analysis
  • FIG. 8 Company matrix analysis, 2021
  • FIG. 9 PESTEL analysis
  • FIG. 10 Key segment trends, by drug class
  • FIG. 11 Key segment trends, by pregnancy stage
  • FIG. 12 Key segment trends, by distribution channel
  • FIG. 13 Key regional trends
  • FIG. 14 Competitive dashboard, 2021
目次
Product Code: 5385

Global Pregnancy Medication Market is set to witness lucrative growth and record a sizeable valuation by 2032, owing to the surging incidences of nutritional deficiencies in expectant mothers. The increasing prevalence of deficiency diseases in pregnant women can be attributed to improper sanitation, lack of hygiene, poor dietary habits, and reproductive health. Lack of essential nutrients during pregnancy can lead to future complications such as anemia and neural tube birth defects.

Based on estimates by the World Health Organization (WHO), approximately 40% of pregnant women globally are anemic. Iron deficiency anemia during pregnancy can lead to preterm delivery, fetal growth restriction, low birth weight, maternal infection, and other complications. To avoid these complexities, doctors prescribe a complete course of antianemia drugs, creating new industry growth prospects.

The pregnancy medication market is segregated based on drug class, pregnancy stage, distribution channel, and region.

With respect to drug class, the vaccines segment is projected to showcase more than 13% CAGR between 2023 and 2032. Certain vaccines administered to ensure the healthy growth of the unborn are safe for pregnant women, propelling their sales throughout the projection period. Besides, these vaccines also protect expecting mothers from acquiring serious illnesses such as hepatitis, bolstering their adoption over the next eight years.

Regarding the pregnancy stage, the 3rd-trimester segment is poised to accumulate decent revenues and record a fair target valuation by 2032. The maturation and development of critical body parts of the fetus, such as the lungs, brain, and kidneys, takes place during this period, significantly increasing the mother's nutritional requirements. The 3rd-trimester of pregnancy is recognized by episodic constipation, heartburn, and other complications, driving the demand for optimal pregnancy medications.

Online pharmacies are expected to amass a noticeable market share and emerge as a prominent distribution channel through 2032. The accelerated consumer shift toward online pharmacies owing to the availability of attractive discounts and offers on a wide range of healthcare and nutritional products will drive segment gains between 2023 and 2032. The increasing popularity of eCommerce websites due to their ease of use and hassle-free doorstep delivery services may create favorable growth scenarios for the pregnancy medication industry.

The Latin America pregnancy medication market is speculated to depict over 12.5% growth rate from 2023 to 2032. The considerable rise in household incomes across developed economies such as Mexico and Brazil will positively influence the regional landscape over the forthcoming years. In addition, the rising awareness about several complications associated with pregnancy and ensuring a healthy pregnancy and post-pregnancy care will ultimately boost business growth.

Table of Contents

Chapter 1 Methodology & Scope

  • 1.1 Market definitions
  • 1.2 Base estimates and working
    • 1.2.1 North America
    • 1.2.2 Europe
    • 1.2.3 Asia pacific
    • 1.2.4 Latin America
    • 1.2.5 MEA
  • 1.3 Forecast calculations
  • 1.4 Data validation
  • 1.5 Data sources
    • 1.5.1 Secondary
      • 1.5.1.1 Paid sources
      • 1.5.1.2 Public sources
    • 1.5.2 Primary

Chapter 2 Executive Summary

  • 2.1 Pregnancy medication industry 360 degree synopsis, 2018 - 2032
    • 2.1.1 Business trends
    • 2.1.2 Drug class trends
    • 2.1.3 Pregnancy stage trends
    • 2.1.4 Distribution channel trends
    • 2.1.5 Regional trends

Chapter 3 Pregnancy Medication Industry Insights

  • 3.1 Industry segmentation
  • 3.2 Industry landscape, 2018 - 2032
  • 3.3 Industry impact forces
    • 3.3.1 Growth drivers
      • 3.3.1.1 Growing incidence of complications during pregnancy
      • 3.3.1.2 Significant benefits of dietary supplements in pregnancy
      • 3.3.1.3 Rising awareness regarding pregnancy care
    • 3.3.2 Industry pitfalls & challenges
      • 3.3.2.1 Side effects and risks associated with the use of other medication
      • 3.3.2.2 Declining birth rate across the world
  • 3.4 Growth potential analysis
    • 3.4.1 By drug class
    • 3.4.2 By pregnancy stage
    • 3.4.3 by distribution channel
  • 3.5 COVID- 19 impact analysis
  • 3.6 Comparative analysis of nutrition recommendations & daily dietary allowances for pregnant and non-pregnant women
  • 3.7 Regulatory landscape
    • 3.7.1 U.S.
    • 3.7.2 Europe
  • 3.8 Porter's analysis
    • 3.8.1 Bargaining power of suppliers
    • 3.8.2 Bargaining power of buyers
    • 3.8.3 Threat of new entrants
    • 3.8.4 Threat of substitutes
    • 3.8.5 Industry rivalry
  • 3.9 PESTLE analysis

Chapter 4 Competitive Landscape, 2021

  • 4.1 Introduction
  • 4.2 Company matrix analysis, 2021
  • 4.3 Strategy dashboard, 2021

Chapter 5 Pregnancy Medication Market, By Drug Class

  • 5.1 Key segment trends
  • 5.2 Antianemia
    • 5.2.1 Market size, by region, 2018 - 2032 (USD Million)
  • 5.3 Antacids
    • 5.3.1 Market size, by region, 2018 - 2032 (USD Million)
  • 5.4 Antiallergic
    • 5.4.1 Market size, by region, 2018 - 2032 (USD Million)
  • 5.5 Analgesics
    • 5.5.1 Market size, by region, 2018 - 2032 (USD Million)
  • 5.6 Antimicrobials
    • 5.6.1 Market size, by region, 2018 - 2032 (USD Million)
  • 5.7 Hormones
    • 5.7.1 Market size, by region, 2018 - 2032 (USD Million)
  • 5.8 Laxatives
    • 5.8.1 Market size, by region, 2018 - 2032 (USD Million)
  • 5.9 Vaccines
    • 5.9.1 Market size, by region, 2018 - 2032 (USD Million)
  • 5.10 Nutritional supplements
    • 5.10.1 Market size, by region, 2018 - 2032 (USD Million)
    • 5.10.2 Minerals
      • 5.10.2.1 Market size, by region, 2018 - 2032 (USD Million)
    • 5.10.3 Omega 3
      • 5.10.3.1 Market size, by region, 2018 - 2032 (USD Million)
    • 5.10.4 Folic acid
      • 5.10.4.1 Market size, by region, 2018 - 2032 (USD Million)
    • 5.10.5 Vitamins
      • 5.10.5.1 Market size, by region, 2018 - 2032 (USD Million)
    • 5.10.6 Multivitamins
      • 5.10.6.1 Market size, by region, 2018 - 2032 (USD Million)
    • 5.10.7 Others
      • 5.10.7.1 Market size, by region, 2018 - 2032 (USD Million)
  • 5.11 Others
    • 5.11.1 Market size, by region, 2018 - 2032 (USD Million)

Chapter 6 Pregnancy Medication Market, By Pregnancy Stage

  • 6.1 Key segment trends
  • 6.2 1st trimester
    • 6.2.1 Market size, by region, 2018 - 2032 (USD Million)
  • 6.3 2nd trimester
    • 6.3.1 Market size, by region, 2018 - 2032 (USD Million)
  • 6.4 3rd trimester
    • 6.4.1 Market size, by region, 2018 - 2032 (USD Million)

Chapter 7 Pregnancy Medication Market, By Distribution Channel

  • 7.1 Key segment trends
  • 7.2 Hospital pharmacy
    • 7.2.1 Market size, by region, 2018 - 2032 (USD Million)
  • 7.3 Retail pharmacy
    • 7.3.1 Market size, by region, 2018 - 2032 (USD Million)
  • 7.4 Online pharmacy
    • 7.4.1 Market size, by region, 2018 - 2032 (USD Million)

Chapter 8 Pregnancy Medication Market, By Region

  • 8.1 Key regional trends
  • 8.2 North America
    • 8.2.1 Market size, by country, 2018 - 2032 (USD Million)
    • 8.2.2 Market size, by drug class, 2018 - 2032 (USD Million)
      • 8.2.2.1 Market size, by nutritional supplements, 2018 - 2032 (USD Million)
    • 8.2.3 Market size, by pregnancy stage, 2018 - 2032 (USD Million)
    • 8.2.4 Market size, by distribution channel, 2018 - 2032 (USD Million)
    • 8.2.5 U.S.
      • 8.2.5.1 Market size, by drug class, 2018 - 2032 (USD Million)
        • 8.2.5.1.1 Market size, by nutritional supplements, 2018 - 2032 (USD Million)
      • 8.2.5.2 Market size, by pregnancy stage, 2018 - 2032 (USD Million)
      • 8.2.5.3 Market size, by distribution channel, 2018 - 2032 (USD Million)
    • 8.2.6 Canada
      • 8.2.6.1 Market size, by drug class, 2018 - 2032 (USD Million)
        • 8.2.6.1.1 Market size, by nutritional supplements, 2018 - 2032 (USD Million)
      • 8.2.6.2 Market size, by pregnancy stage, 2018 - 2032 (USD Million)
      • 8.2.6.3 Market size, by distribution channel, 2018 - 2032 (USD Million)
  • 8.3 Europe
    • 8.3.1 Market size, by country, 2018 - 2032 (USD Million)
    • 8.3.2 Market size, by drug class, 2018 - 2032 (USD Million)
      • 8.3.2.1 Market size, by nutritional supplements, 2018 - 2032 (USD Million)
    • 8.3.3 Market size, by pregnancy stage, 2018 - 2032 (USD Million)
    • 8.3.4 Market size, by distribution channel, 2018 - 2032 (USD Million)
    • 8.3.5 Germany
      • 8.3.5.1 Market size, by drug class, 2018 - 2032 (USD Million)
        • 8.3.5.1.1 Market size, by nutritional supplements, 2018 - 2032 (USD Million)
      • 8.3.5.2 Market size, by pregnancy stage, 2018 - 2032 (USD Million)
      • 8.3.5.3 Market size, by distribution channel, 2018 - 2032 (USD Million)
    • 8.3.6 UK
      • 8.3.6.1 Market size, by drug class, 2018 - 2032 (USD Million)
        • 8.3.6.1.1 Market size, by nutritional supplements, 2018 - 2032 (USD Million)
      • 8.3.6.2 Market size, by pregnancy stage, 2018 - 2032 (USD Million)
      • 8.3.6.3 Market size, by distribution channel, 2018 - 2032 (USD Million)
    • 8.3.7 France
      • 8.3.7.1 Market size, by drug class, 2018 - 2032 (USD Million)
        • 8.3.7.1.1 Market size, by nutritional supplements, 2018 - 2032 (USD Million)
      • 8.3.7.2 Market size, by pregnancy stage, 2018 - 2032 (USD Million)
      • 8.3.7.3 Market size, by distribution channel, 2018 - 2032 (USD Million)
    • 8.3.8 Italy
      • 8.3.8.1 Market size, by drug class, 2018 - 2032 (USD Million)
        • 8.3.8.1.1 Market size, by nutritional supplements, 2018 - 2032 (USD Million)
      • 8.3.8.2 Market size, by pregnancy stage, 2018 - 2032 (USD Million)
      • 8.3.8.3 Market size, by distribution channel, 2018 - 2032 (USD Million)
    • 8.3.9 Spain
      • 8.3.9.1 Market size, by drug class, 2018 - 2032 (USD Million)
        • 8.3.9.1.1 Market size, by nutritional supplements, 2018 - 2032 (USD Million)
      • 8.3.9.2 Market size, by pregnancy stage, 2018 - 2032 (USD Million)
      • 8.3.9.3 Market size, by distribution channel, 2018 - 2032 (USD Million)
  • 8.4 Asia Pacific
    • 8.4.1 Market size, by country, 2018 - 2032 (USD Million)
    • 8.4.2 Market size, by drug class, 2018 - 2032 (USD Million)
      • 8.4.2.1 Market size, by nutritional supplements, 2018 - 2032 (USD Million)
    • 8.4.3 Market size, by pregnancy stage, 2018 - 2032 (USD Million)
    • 8.4.4 Market size, by distribution channel, 2018 - 2032 (USD Million)
    • 8.4.5 China
      • 8.4.5.1 Market size, by drug class, 2018 - 2032 (USD Million)
        • 8.4.5.1.1 Market size, by nutritional supplements, 2018 - 2032 (USD Million)
      • 8.4.5.2 Market size, by pregnancy stage, 2018 - 2032 (USD Million)
      • 8.4.5.3 Market size, by distribution channel, 2018 - 2032 (USD Million)
    • 8.4.6 Japan
      • 8.4.6.1 Market size, by drug class, 2018 - 2032 (USD Million)
        • 8.4.6.1.1 Market size, by nutritional supplements, 2018 - 2032 (USD Million)
      • 8.4.6.2 Market size, by pregnancy stage, 2018 - 2032 (USD Million)
      • 8.4.6.3 Market size, by distribution channel, 2018 - 2032 (USD Million)
    • 8.4.7 India
      • 8.4.7.1 Market size, by drug class, 2018 - 2032 (USD Million)
        • 8.4.7.1.1 Market size, by nutritional supplements, 2018 - 2032 (USD Million)
      • 8.4.7.2 Market size, by pregnancy stage, 2018 - 2032 (USD Million)
      • 8.4.7.3 Market size, by distribution channel, 2018 - 2032 (USD Million)
    • 8.4.8 Australia
      • 8.4.8.1 Market size, by drug class, 2018 - 2032 (USD Million)
        • 8.4.8.1.1 Market size, by nutritional supplements, 2018 - 2032 (USD Million)
      • 8.4.8.2 Market size, by pregnancy stage, 2018 - 2032 (USD Million)
      • 8.4.8.3 Market size, by distribution channel, 2018 - 2032 (USD Million)
    • 8.4.9 South Korea
      • 8.4.9.1 Market size, by drug class, 2018 - 2032 (USD Million)
        • 8.4.9.1.1 Market size, by nutritional supplements, 2018 - 2032 (USD Million)
      • 8.4.9.2 Market size, by pregnancy stage, 2018 - 2032 (USD Million)
      • 8.4.9.3 Market size, by distribution channel, 2018 - 2032 (USD Million)
  • 8.5 Latin America
    • 8.5.1 Market size, by country, 2018 - 2032 (USD Million)
    • 8.5.2 Market size, by drug class, 2018 - 2032 (USD Million)
      • 8.5.2.1 Market size, by nutritional supplements, 2018 - 2032 (USD Million)
    • 8.5.3 Market size, by pregnancy stage, 2018 - 2032 (USD Million)
    • 8.5.4 Market size, by distribution channel, 2018 - 2032 (USD Million)
    • 8.5.5 Brazil
      • 8.5.5.1 Market size, by drug class, 2018 - 2032 (USD Million)
        • 8.5.5.1.1 Market size, by nutritional supplements, 2018 - 2032 (USD Million)
      • 8.5.5.2 Market size, by pregnancy stage, 2018 - 2032 (USD Million)
      • 8.5.5.3 Market size, by distribution channel, 2018 - 2032 (USD Million)
    • 8.5.6 Mexico
      • 8.5.6.1 Market size, by drug class, 2018 - 2032 (USD Million)
        • 8.5.6.1.1 Market size, by nutritional supplements, 2018 - 2032 (USD Million)
      • 8.5.6.2 Market size, by pregnancy stage, 2018 - 2032 (USD Million)
      • 8.5.6.3 Market size, by distribution channel, 2018 - 2032 (USD Million)
    • 8.5.7 Argentina
      • 8.5.7.1 Market size, by drug class, 2018 - 2032 (USD Million)
        • 8.5.7.1.1 Market size, by nutritional supplements, 2018 - 2032 (USD Million)
      • 8.5.7.2 Market size, by pregnancy stage, 2018 - 2032 (USD Million)
      • 8.5.7.3 Market size, by distribution channel, 2018 - 2032 (USD Million)
  • 8.6 Middle East & Africa
    • 8.6.1 Market size, by country, 2018 - 2032 (USD Million)
    • 8.6.2 Market size, by drug class, 2018 - 2032 (USD Million)
      • 8.6.2.1 Market size, by nutritional supplements, 2018 - 2032 (USD Million)
    • 8.6.3 Market size, by pregnancy stage, 2018 - 2032 (USD Million)
    • 8.6.4 Market size, by distribution channel, 2018 - 2032 (USD Million)
    • 8.6.5 South Africa
      • 8.6.5.1 Market size, by drug class, 2018 - 2032 (USD Million)
        • 8.6.5.1.1 Market size, by nutritional supplements, 2018 - 2032 (USD Million)
      • 8.6.5.2 Market size, by pregnancy stage, 2018 - 2032 (USD Million)
      • 8.6.5.3 Market size, by distribution channel, 2018 - 2032 (USD Million)
    • 8.6.6 Saudi Arabia
      • 8.6.6.1 Market size, by drug class, 2018 - 2032 (USD Million)
        • 8.6.6.1.1 Market size, by nutritional supplements, 2018 - 2032 (USD Million)
      • 8.6.6.2 Market size, by pregnancy stage, 2018 - 2032 (USD Million)
      • 8.6.6.3 Market size, by distribution channel, 2018 - 2032 (USD Million)
    • 8.6.7 UAE
      • 8.6.7.1 Market size, by drug class, 2018 - 2032 (USD Million)
        • 8.6.7.1.1 Market size, by nutritional supplements, 2018 - 2032 (USD Million)
      • 8.6.7.2 Market size, by pregnancy stage, 2018 - 2032 (USD Million)
      • 8.6.7.3 Market size, by distribution channel, 2018 - 2032 (USD Million)

Chapter 9 Company Profiles

  • 9.1 F. Hoffmann-La Roche Ltd
    • 9.1.1 Business overview
    • 9.1.2 Financial data
    • 9.1.3 Product landscape
    • 9.1.4 Strategic outlook
    • 9.1.5 SWOT analysis
  • 9.2 Alkem Laboratories Limited
    • 9.2.1 Business overview
    • 9.2.2 Financial data
    • 9.2.3 Product landscape
    • 9.2.4 Strategic outlook
    • 9.2.5 SWOT analysis
  • 9.3 Piramal Enterprises Limited
    • 9.3.1 Business overview
    • 9.3.2 Financial data
    • 9.3.3 Product landscape
    • 9.3.4 Strategic outlook
    • 9.3.5 SWOT analysis
  • 9.4 Cipla Limited
    • 9.4.1 Business overview
    • 9.4.2 Financial data
    • 9.4.3 Product landscape
    • 9.4.4 Strategic outlook
    • 9.4.5 SWOT analysis
  • 9.5 Pfizer Inc
    • 9.5.1 Business overview
    • 9.5.2 Financial data
    • 9.5.3 Product landscape
    • 9.5.4 Strategic outlook
    • 9.5.5 SWOT analysis
  • 9.6 Dr. Reddy's Laboratories
    • 9.6.1 Business overview
    • 9.6.2 Financial data
    • 9.6.3 Product landscape
    • 9.6.4 Strategic outlook
    • 9.6.5 SWOT analysis
  • 9.7 Alembic Pharmaceuticals Ltd
    • 9.7.1 Business overview
    • 9.7.2 Financial data
    • 9.7.3 Product landscape
    • 9.7.4 Strategic outlook
    • 9.7.5 SWOT analysis
  • 9.8 Lupin Limited
    • 9.8.1 Business overview
    • 9.8.2 Financial data
    • 9.8.3 Product landscape
    • 9.8.4 Strategic outlook
    • 9.8.5 SWOT analysis
  • 9.9 Glenmark Pharmaceuticals Ltd
    • 9.9.1 Business overview
    • 9.9.2 Financial data
    • 9.9.3 Product landscape
    • 9.9.4 Strategic outlook
    • 9.9.5 SWOT analysis
  • 9.10 Viatris Inc. (Mylan Inc.)
    • 9.10.1 Business overview
    • 9.10.2 Financial data
    • 9.10.3 Product landscape
    • 9.10.4 Strategic outlook
    • 9.10.5 SWOT analysis
  • 9.11 Amgen Inc
    • 9.11.1 Business overview
    • 9.11.2 Financial data
    • 9.11.3 Product landscape
    • 9.11.4 Strategic outlook
    • 9.11.5 SWOT analysis